INNO and INNPD Related Headlines
Go Back- Innocan Pharma receives third consecutive FDA fee waiver for dog pain drug
- FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time
- Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
- Innocan Pharma anticipates NYSE American listing around January 7
- Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
INNO and INNPD Related Press Releases
Go Back- FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time
- Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
- Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
INNO and INNPD Related SEC Filings
Go Back- Form FWP INNOCAN PHARMA Corp Filed by: INNOCAN PHARMA Corp
- Form F-1/A INNOCAN PHARMA Corp
- Form FWP INNOCAN PHARMA Corp Filed by: INNOCAN PHARMA Corp
- Form F-1 INNOCAN PHARMA Corp
- Form RW INNOCAN PHARMA Corp
- Form EFFECT INNOCAN PHARMA Corp
- Form F-1/A INNOCAN PHARMA Corp
- Form FWP INNOCAN PHARMA Corp Filed by: INNOCAN PHARMA Corp
- Form F-1/A INNOCAN PHARMA Corp
- Form 8-A12B/A INNOCAN PHARMA Corp
- Form 8-A12B/A INNOCAN PHARMA Corp
- Form 8-A12B/A INNOCAN PHARMA Corp
- Form FWP INNOCAN PHARMA Corp Filed by: INNOCAN PHARMA Corp
- Form F-1/A INNOCAN PHARMA Corp
- Form DEL AM INNOCAN PHARMA Corp
- Form F-1/A INNOCAN PHARMA Corp
- Form FWP INNOCAN PHARMA Corp Filed by: INNOCAN PHARMA Corp
- Form F-1/A INNOCAN PHARMA Corp
- Form 8-A12B INNOCAN PHARMA Corp
- Form FWP INNOCAN PHARMA Corp Filed by: INNOCAN PHARMA Corp
